Fidson Healthcare Announces Strategic Partnership with Leading Japanese Pharmaceutical Company

Must Read

Jumia is battling with $17 million fraud alongside several US lawsuit

Jumia has revealed some shocking revelations this week, Africa’s largest e-commerce operator has suspended some staff over an $18m...

How ₦50 Entry Strategy impacted Oride Bike Hailing Success in Ibadan

One would have thought that the introduction of ORide, a bike hailing system backed by its specialized application (Opay...

Africa’s fastest train line completely operational

Africa’s fastest train line is fully operational. Railway infrastructure constructor Colas Rail, who built the project announced the reports. Al Boraq...
- Advertisement -
- Advertisement -

Fidson Healthcare Plc (Fidson), one of Nigeria’s leading pharmaceutical manufacturers, hereby announces the execution of a strategic alliance with Ohara Pharmaceutical Co. Ltd (Ohara), a leading Japanese healthcare company. This alliance is a result of Fidson’s recent Rights Issue which saw Ohara’s shareholding in the company increased to 21.57%.

The strategic alliance is aimed at supporting Fidson in fulfilling its commitment to provide the Nigerian market with the latest healthcare products and services. Ohara, being a major player in the Asian pharmaceutical market, will bring cutting edge technology and innovation through technology transfer, expertise, and knowledge sharing to enhance Fidson’s excellence and ascendency in the Nigerian pharma space.

Read:  Nigeria Ranks Second Worst Electricity Supply Nation

The alliance holds promise as a significant growth driver for both companies, particularly as a major factor for the development of local pharmaceutical manufacturing in Nigeria.

The significance of collaborations of this nature to the emerging Nigerian healthcare system is evidently enormous, given the rapid population growth, the healthcare state and the living standards of the larger population in the country.

Given this growing population, there is no doubt that Nigeria is in urgent need of a rapid improvement in the standard of healthcare delivery. This can only be accelerated through modernization and technological intervention which the alliance with Ohara aims to deliver.

Read:  Impact Week 2017 - Lufthansa to Train 200 Unilag Students

About Ohara Pharmaceutical Co., Ltd

Read:  Fidson Lists Extra 586 Million Shares On Stock Exchange

Ohara Pharmaceutical Co., Ltd. is a pharmaceutical company focusing on the businesses of orphan drugs and generic drugs. Its mid-term 3-year business plan started in FY2018 under the catchphrase “Challenge 2020,” with the key objective of “addressing unmet medical needs,” to advance management innovations and make the next leap forward. The company focuses on the development and marketing of orphan drugs mainly in the field of pediatric oncology and on the development, manufacture, and marketing of generic drugs that give extra consideration to the prevention of medical accidents. Ohara plans to further expand these businesses into emerging countries, primarily in the Asian and African regions.

- Advertisement -

Subscribe to BrandSpur Ng

Subscribe for latest updates. Signup to best of brands and business news, informed analysis and opinions among others that can propel you, your business or brand to greater heights.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Latest News

Jumia is battling with $17 million fraud alongside several US lawsuit

Jumia has revealed some shocking revelations this week, Africa’s largest e-commerce operator has suspended some staff over an $18m...

Jumia reports Q2 2019 Results: Continued strong growth of top-line drivers and 94% increase in Gross profit

Jumia Technologies AG (NYSE: JMIA) ("Jumia" or the Company) announced today its financial results for the quarter ended June 30, 2019. "We continue to deliver...

Nimbus Media introduces new “in-house” digital screen technology

Nimbus Media, a frontline in-house advertising company has introduced a new look digital screen display technology saying that the new innovation is targeted at...

Kano, Zamfara and Cross River residents paid highest transport fares in July – NBS

Residents of Kano, Zamfara and Cross River paid the highest intra-city bus journey fares in Nigeria in July, the National Bureau of Statistics (NBS)...

More Articles Like This